616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities

616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities

Bibliographic Details
Main Authors:	John Conklin, Kai Sun, Roberta Vezza Alexander, Jennifer Rogers, Amanda Eudy, Jayanth Doss, Rebecca Sadun, Lisa Criscione Schreiber, Kelley Brady, Megan Clowse
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-12-01
Series:	Lupus Science and Medicine

Similar Items

Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study
by: Kai Sun, et al.
Published: (2023-12-01)

Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
by: David S Pisetsky, et al.
Published: (2023-11-01)

Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
by: David S Pisetsky, et al.
Published: (2022-07-01)

615 A pilot study to implement the Type 1 & 2 SLE Model into clinical care
by: David S Pisetsky, et al.
Published: (2022-12-01)

Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
by: Dennis Levinson, et al.
Published: (2022-10-01)

Bilik 616 /
by: Zaifuzaman Ahmad, 1969- 516512
Published: (2011)

Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses
by: Tony Muchamuel, et al.
Published: (2023-03-01)

Zebra bodies in lupus nephritis after hydroxychloroquine therapy
by: Anshima Singh, et al.
Published: (2023-05-01)

Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease
by: Valerie Smith, et al.
Published: (2024-01-01)

Molecular endotypes of type 1 and type 2 SLE
by: Peter Lipsky, et al.
Published: (2023-01-01)

Mazda 616 1970-79 autobook/
Published: (1979)

S15.1 Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
by: S Fasano, et al.
Published: (2022-10-01)

Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis
by: Ning An, et al.
Published: (2022-01-01)

AGW 616 - MANAGEMENT INFORMATION SYSTEM SEPT. 1999.
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

AGW 616 - MANAGEMENT INFORMATION SYSTEM APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW 616 - MANAGEMENT INFORMATION SYSTEM SEPT 1999.
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
by: Peng-Cheng Liu, et al.
Published: (2024-04-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
by: Atsushi Manabe, et al.
Published: (2024-04-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
by: Noël Zahr, et al.
Published: (2021-03-01)

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
by: Joan T Merrill, et al.
Published: (2022-12-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
by: Bajwa A, et al.
Published: (2015-05-01)

624 The Molecular Endotypes of Type 1 and Type 2 SLE
by: David S Pisetsky, et al.
Published: (2022-12-01)

AGW 616 - MANAGEMENT INFORMATION SYSTEM SEPT 1999.pdf
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report
by: Alice Verdelli, et al.
Published: (2023-10-01)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
by: Jae-Eun Lee, et al.
Published: (2023-05-01)

501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus
by: Michelle Petri, et al.
Published: (2022-12-01)

Epworth Sleepiness Scale outcome in 616 brazilian medical students Desempenho na Escala de Sonolência de Epworth de 616 estudantes de medicina brasileiros
by: Flávio Alóe, et al.
Published: (1997-06-01)

Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial
by: E Schmitt, et al.
Published: (2022-07-01)

Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
by: Chiharu Hidekawa, et al.
Published: (2023-09-01)

Intranasal phototherapy for allergic rhinitis: Interventional procedures guidance [IPG616]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2018)

Mesoscale analysis on the "6.16" heavy precipitation event in the west of Xinjiang
by: Yong ZENG, et al.
Published: (2020-02-01)

Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China
by: Xuan Huang, et al.
Published: (2023-09-01)

Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus
by: Risa Wakiya, et al.
Published: (2022-06-01)

A glimpse into the future of systemic lupus erythematosus
by: Martin Aringer, et al.
Published: (2022-03-01)

Hydroxychloroquine retinopathy.
by: Yusuf, I, et al.
Published: (2017)

LO-026 Hydroxychloroquine use in pregnant women with systemic lupus erythematosus and major congenital malformations in the offspring
by: Elisabet Svenungsson, et al.
Published: (2023-07-01)

1601 No increased risk of arrhythmia among patients with systemic lupus erythematosus or rheumatoid arthritis using hydroxychloroquine
by: Na Lu, et al.
Published: (2022-12-01)

Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic
by: Mercadé‐Besora, N, et al.
Published: (2024)